Manuales, Vilma B.
HRN: 21-47-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2022
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
08/23/2022
08/29/2022
IV
750mg
Q25hrs
CAP-HR/HAP
Waiting Final Action
Indication: Empirical Escalation Type of Infection: PneumoniaUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes